Bristol-Myers Squibb (BMY) Stock Buyback History
TTM buyback yield N/A.
TTM buyback yield
N/A
Shareholder yield (TTM)
N/A
5Y share count change
-9.6%
TTM buyback spend
N/A
SBC coverage (TTM)
0.00x
Diluted vs basic shares (annual)
Weighted average shares from the income statement: diluted (EPS denominator and typical buyback-yield basis) compared with basic.
Shares outstanding (annual)
Year-over-year change in diluted weighted average shares (industry-standard for EPS and per-share capital return). Green is fewer shares vs the prior fiscal year; red is growth (dilution). The earliest year shown has no prior year to compare.
Dividend & buyback yield
Buybacks vs stock-based compensation
TTM coverage: 0.00x (buybacks ÷ SBC). Bars are fiscal-year totals.
Buyback spending history
| Year | Buybacks | SBC | Net | Shares (dil.) | YoY shares | Buyback yield |
|---|---|---|---|---|---|---|
| 2025 | $0.00 | $553.00M | −$553.00M | 2.04B | 0.7% | — |
| 2024 | $0.00 | $507.00M | −$507.00M | 2.03B | -2.5% | — |
| 2023 | $5.16B | $518.00M | $4.64B | 2.08B | -3.2% | 4.96% |
| 2022 | $8.00B | $457.00M | $7.54B | 2.15B | -4.4% | 5.28% |
| 2021 | $6.29B | $583.00M | $5.70B | 2.25B | -0.6% | 4.68% |
| 2020 | $1.55B | $779.00M | $767.00M | 2.26B | 31.9% | 1.11% |
| 2019 | $7.30B | $441.00M | $6.86B | 1.71B | 4.6% | 5.94% |
| 2018 | $320.00M | $221.00M | $99.00M | 1.64B | -0.9% | 0.38% |
| 2017 | $2.47B | $199.00M | $2.27B | 1.65B | -1.7% | 2.46% |
| 2016 | $231.00M | $205.00M | $26.00M | 1.68B | 0.1% | 0.24% |
| 2015 | $0.00 | $235.00M | −$235.00M | 1.68B | 0.5% | — |
| 2014 | $0.00 | $213.00M | −$213.00M | 1.67B | 0.5% | — |
| 2013 | $433.00M | $191.00M | $242.00M | 1.66B | -1.5% | 0.49% |
| 2012 | $2.40B | $154.00M | $2.25B | 1.69B | -1.7% | 4.49% |
| 2011 | $1.22B | $161.00M | $1.06B | 1.72B | -0.6% | 2.05% |
| 2010 | $576.00M | $193.00M | $383.00M | 1.73B | -12.7% | 1.27% |
| 2009 | $0.00 | $183.00M | −$183.00M | 1.98B | -1.1% | — |
| 2008 | $0.00 | $181.00M | −$181.00M | 2.00B | 1.1% | — |
| 2007 | $0.00 | $0.00 | $0.00 | 1.98B | 0.9% | — |
| 2006 | $0.00 | $0.00 | $0.00 | 1.96B | -1.0% | — |
| 2005 | $0.00 | $0.00 | $0.00 | 1.98B | 0.4% | — |
| 2004 | $0.00 | $0.00 | $0.00 | 1.98B | 1.3% | — |
| 2003 | $0.00 | $0.00 | $0.00 | 1.95B | -3.3% | — |
| 2002 | $164.00M | $0.00 | $164.00M | 2.02B | 2.6% | 0.32% |
| 2001 | $1.59B | $0.00 | $1.59B | 1.97B | -1.6% | 1.61% |
| 2000 | $2.34B | $0.00 | $2.34B | 2.00B | -1.5% | — |
| 1999 | $1.42B | $0.00 | $1.42B | 2.03B | -0.2% | — |
| 1998 | $1.56B | $0.00 | $1.56B | 2.03B | -0.5% | — |
| 1997 | $1.16B | $0.00 | $1.16B | 2.04B | 0.3% | — |
| 1996 | $852.00M | $0.00 | $852.00M | 2.04B | — | — |
| 1995 | $244.00M | $0.00 | $244.00M | — | — | — |
| 1994 | $701.00M | $0.00 | $701.00M | — | — | — |
| 1993 | $419.00M | $0.00 | $419.00M | — | — | — |
| 1992 | $228.00M | $0.00 | $228.00M | — | — | — |
| 1991 | $447.00M | $0.00 | $447.00M | — | — | — |
| 1990 | $562.00M | $0.00 | $562.00M | — | — | — |
| 1989 | $51.00M | $0.00 | $51.00M | — | — | — |
Buybacks vs dividends (share of cash returned)
Buyback capacity (TTM)
TTM buybacks vs headroom (FCF − dividends, TTM)0% of headroom
Headroom $7.80B (TTM FCF − TTM dividends, clamped at zero).
Frequently asked questions
Does Bristol-Myers Squibb buy back its own stock?
- Yes, Bristol-Myers Squibb (BMY) has repurchased shares in recent periods. See the history table and charts on this page for amounts and trends.
Is Bristol-Myers Squibb diluting shareholders?
- Compare stock-based compensation (SBC) to buybacks in the chart above. Net effect varies by year; see annual buyback vs SBC bars and the history table.
How has Bristol-Myers Squibb's share count changed?
- Diluted weighted average shares changed by about -9.6% over roughly five fiscal years (annual income statement data).